Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010–2015

Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010–2015

Thamir M Alshammari,1–3 Sondus I Ata,4 Mansour Adam Mahmoud,5 Tariq M Alhawassi,2,4,6 Hisham S Aljadhey3 1Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia; 2Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia; 3Saudi Foo...

Full description

Bibliographic Details
Main Authors: Alshammari TM, Ata SI, Mahmoud MA, Alhawassi TM, Aljadhey HS
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Warfarin
Dabigatran
Rivaroxaban
FAERS
Bleeding
Online Access:https://www.dovepress.com/signals-of-bleeding-among-direct-acting-oral-anticoagulant-users-compa-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/signals-of-bleeding-among-direct-acting-oral-anticoagulant-users-compa-peer-reviewed-article-TCRM

Similar Items